Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07765394
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic HealthCitruslabsCompletedNot Applicable
NCT07765394Completed
Not Applicable
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of...Citruslabs
NCT07765017
Early Mobilization and Prolonged ICU Stay in Postoperative PatientsAnkara Training and Research HospitalNot Yet Recruiting
NCT07765017Not Yet Recruiting
—
Early Mobilization and Prolonged ICU Stay in Postoperative PatientsAnkara Training and Resea...
NCT07766629
Recovery Trajectories After Propofol-Based Intravenous Anesthesia in Toddlers and Older ChildrenAssiut UniversityNot Yet Recruiting
NCT07766629Not Yet Recruiting
—
Recovery Trajectories After Propofol-Based Intravenous Anesthesia in Toddlers an...Assiut University
NCT07764835
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)AstraZenecaNot Yet Recruiting
NCT07764835Not Yet Recruiting
—
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patie...AstraZeneca
NCT07766499
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of THB335 in Adult Participants With Chronic Spontaneous Urticaria (CSU)Calixis Inc.Not Yet RecruitingPhase 2
NCT07766499Not Yet Recruiting
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multice...Calixis Inc.
NCT07765940
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate CancerRadAlliance Therapeutics, IncNot Yet RecruitingPhase 1
NCT07765940Not Yet Recruiting
Phase 1
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Can...RadAlliance Therapeutics,...
NCT07764458
Recovery Legal Care Randomized TrialEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)RecruitingNot Applicable
NCT07764666
Compare the Impact of Sodium Hypochlorite and Saline Irrigation Protocols With and Without Cryotherapy on Post-operative Pain Following Pulpotomy in Permanent Mandibular Molar Teeth. "Randomized Controlled Trial"Abdelrahman Refaat Khalaf AhmedEnrolling By InvitationNot Applicable
NCT07764666Enrolling By Invitation
Not Applicable
Compare the Impact of Sodium Hypochlorite and Saline Irrigation Protocols With a...Abdelrahman Refaat Khalaf...
NCT07765563
Reliability of Expired Allergens in Patch Testing: A Comparative Study With Non-Expired SeriesUniversity of CalgaryNot Yet RecruitingPhase 4
NCT07765563Not Yet Recruiting
Phase 4
Reliability of Expired Allergens in Patch Testing: A Comparative Study With Non-...University of Calgary
NCT07765433
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract CancerECOG-ACRIN Cancer Research GroupNot Yet RecruitingPhase 2
NCT07765433Not Yet Recruiting
Phase 2
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared...ECOG-ACRIN Cancer Researc...
NCT07764549
Salivary TNF-α, FoxO-1, and SIRT-1 Levels in Periodontitis and SmokingZehra HasgülCompleted
NCT07764549Completed
—
Salivary TNF-α, FoxO-1, and SIRT-1 Levels in Periodontitis and SmokingZehra Hasgül
NCT07766486
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation TherapyFondazione del Piemonte per l'OncologiaActive Not RecruitingNot Applicable
NCT07766486Active Not Recruiting
Not Applicable
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormo...Fondazione del Piemonte p...
NCT07764705
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07764705Not Yet Recruiting
Phase 1
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceut...
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZenecaRecruitingPhase 3
NCT07764978Recruiting
Phase 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZeneca
NCT07764744
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic VariantsM.D. Anderson Cancer CenterNot Yet RecruitingNot Applicable
NCT07764744Not Yet Recruiting
Not Applicable
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals Wit...M.D. Anderson Cancer Cent...
NCT07765992
AI-Based Oxytocin-Stimulated Smart Lactation Support VestSelcuk UniversityNot Yet RecruitingNot Applicable
NCT07765992Not Yet Recruiting
Not Applicable
AI-Based Oxytocin-Stimulated Smart Lactation Support VestSelcuk University
NCT07764588
Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial InfarctionShanghai 10th People's HospitalRecruiting
NCT07764588Recruiting
—
Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infa...Shanghai 10th People's Ho...
NCT07766694
Evaluating the Preferences and Tradeoffs of AI-based Electronic Consultations for Older Adults in Primary CareUniversity of PennsylvaniaNot Yet RecruitingNot Applicable
NCT07766694Not Yet Recruiting
Not Applicable
Evaluating the Preferences and Tradeoffs of AI-based Electronic Consultations fo...University of Pennsylvani...
NCT07765342
Diastolic Shock Index for Predicting Postspinal HypotensionIstinye UniversityNot Yet Recruiting
NCT07765342Not Yet Recruiting
—
Diastolic Shock Index for Predicting Postspinal HypotensionIstinye University
NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese ParticipantsInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 1
NCT07765160Not Yet Recruiting
Phase 1
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Parti...Innovent Biologics (Suzho...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Phase 41 (5%)
Phase 31 (5%)